About Cadila Healthcare
Cadila Healthcare or Zydus Cadila – an India based pharmaceutical company having presence around the world.
Cadila Healthcare Ltd. under the aegis of the Zydus Group is set up in the year 1995 and have international presence in countries as -
- Zydus Healthcare (USA) LLC, our subsidiary in the US.
- Zydus Pharmaceuticals USA. Inc supplies finished dosage formulations to the US generic market.
- Zydus France SAS France. With product basket of 90 generic registrations.
- Zydus Healthcare Brasil Limitada , subsidiary in Brazil set up to market formulations.
|Latest Financial Figures||(Figures in Rs. Crores)|
|ET 500 Rank(2011)||165|
|Profit after Tax(PAT)||711|
|MCAP (Market Capitalization)||15470.21|
Cadila Healthcare product portfolio covers areas like formulations, Active Pharmaceutical Ingredients (API), diagnostics, health & dietetic foods, skin care and animal health-care.
Cadila Healthcare core divisions includes -
- Zydus Cadila.
- Zydus Alidac.
- Zydus Medica.
- Zydus Biogen.
- Zydus Neurosciences.
- Zydus Vaccicare.
Cadila Healthcare brands
Oflin OD, Clodus, NeoLoridin, Ven-OD, Isbis, Bonmax, Cartup, Zyquin, Oxeptal, Zytonin, Cefinar, Zycolchin, Dactive, Vageston, Xet, Aldren, Serlin, Mexate, Epsolin, Euglim, Olandus, Divalpro, Topiram, Cytolog, Stilnite, Mifegest, Linid, Mosadac, Espra, Salazar, Lamidus, Zoldac and Zydalis
It is headed by Mr Pankaj R. Patel , Chairman and Managing Director . Cadila Healthcare Corporate Headquarter is located at:
Satellite Cross Roads,
Web site: www.zyduscadila.com
Last Updated on May 21, 2015